Global Dry Eye Syndrome Treatment Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Dry Eye Syndrome Treatment Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Disease Type (Evaporative Dry Eye Syndrome, and Aqueous Deficient Dry Eye Syndrome), Drug Type (Restasis, Xiidra, Cequa, Eysuvis, Tyrvaya, and Others), Treatment Type (Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Dry Eye Syndrome Treatment Market was valued at USD 6,728.3 million in 2023 and is expected to reach USD 12,639.3 million by 2031 while growing at a CAGR of 8.2% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global dry eye syndrome treatment market growth. Dry eye syndrome treatment aims to alleviate symptoms, improve tear production and quality, and protect the ocular surface.
The rising prevalence of Dry Eye Syndrome, coupled with ongoing advancements in ophthalmic technologies like novel drug delivery systems, ocular surface imaging Disease Types, and diagnostic tools, improves the efficacy and convenience of dry eye treatments. Nevertheless, limited treatment efficacy and cost constraints impede the market's growth.
Furthermore, the global dry eye syndrome treatment industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Disease Type Analysis
The Global Dry Eye Syndrome Treatment Market is segmented among Evaporative Dry Eye Syndrome, and Aqueous Deficient Dry Eye Syndrome, based on Disease Type. In 2023, Evaporative Dry Eye Syndrome accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Drug Type Analysis
The Global Dry Eye Syndrome Treatment Market is segmented among Restasis, Xiidra, Cequa, Eysuvis, Tyrvaya, and Others, based on Treatment Type. In 2023, Restasis accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Dry Eye Syndrome Treatment Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Novartis AG, AbbVie, Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceutical Co., Ltd., AFT Pharmaceuticals, Johnson & Johnson Services, Inc., Otsuka Pharmaceutical Co., Ltd., OASIS Medical, Oyster Point Pharma, Inc., and Bausch & Lomb
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Dry Eye Syndrome Treatment Market Dynamics
Drivers
Restraints
Opportunity
4. Global Dry Eye Syndrome Treatment Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Dry Eye Syndrome Treatment Market Segmentation, By Disease Type
Global Dry Eye Syndrome Treatment Market Share Analysis, By Disease Type
Global Dry Eye Syndrome Treatment Market Growth Analysis, By Disease Type
Global Dry Eye Syndrome Treatment Market Trends, By Disease Type
o Evaporative Dry Eye Syndrome
o Aqueous Deficient Dry Eye Syndrome
6. Global Dry Eye Syndrome Treatment Market Segmentation, By Drug Type
Global Dry Eye Syndrome Treatment Market Share Analysis, By Drug Type
Global Dry Eye Syndrome Treatment Market Growth Analysis, By Drug Type
Global Dry Eye Syndrome Treatment Market Trends, By Drug Type
o Restasis
o Xiiidra
o Cequa
o Eysuvis
o Tyrvaya
o Others
7. Global Dry Eye Syndrome Treatment Market Segmentation, By Treatment Type
Global Dry Eye Syndrome Treatment Market Share Analysis, By Treatment Type
Global Dry Eye Syndrome Treatment Market Growth Analysis, By Treatment Type
Global Dry Eye Syndrome Treatment Market Trends, By Treatment Type
o Cyclosporine
o Topical Corticosteroids
o Artificial Tears
o Punctal Plugs
o Oral Omega Supplements
o Others
8. Global Dry Eye Syndrome Treatment Market Segmentation, By Distribution Channel
Global Dry Eye Syndrome Treatment Market Share Analysis, By Distribution Channel
Global Dry Eye Syndrome Treatment Market Growth Analysis, By Distribution Channel
Global Dry Eye Syndrome Treatment Market Trends, By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
9. Global Dry Eye Syndrome Treatment Market Segmentation, By Region
Global Dry Eye Syndrome Treatment Market Share Analysis, By Region
Global Dry Eye Syndrome Treatment Market Growth Analysis, By Region
Global Dry Eye Syndrome Treatment Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
10. Competitive Landscape
Novartis AG*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
AbbVie, Inc.
Sun Pharmaceutical Industries Ltd.
Santen Pharmaceutical Co., Ltd.
AFT Pharmaceuticals
Johnson & Johnson Services, Inc.
Otsuka Pharmaceutical Co., Ltd.
OASIS Medical
Oyster Point Pharma, Inc.
Bausch & Lomb
*Similar analysis will be provided for each company listed above.
